China-Biotics, Inc. Announces Appointment of New Transfer Agent Effective August 15, 2008

    SHANGHAI, China, July 15 /Xinhua-EMWNews-FirstCall/ --

China-Biotics, Inc. (OTC Bulletin Board: CHBT) ("China-Biotics," "the

Company"), a leading Chinese firm specializing in the manufacture,

research, development, marketing and distribution of probiotics products,

today announced the appointment of American Stock Transfer & Trust Company

("AST") as its new transfer agent and registrar, effective August 15, 2008.

AST, headquartered in New York, New York, replaces the Company's former

transfer agent and registrar, American Registrar & Transfer Company.



    Consistently ranked #1 in the prestigious Group Five survey, AST has

pioneered a unique, customer-driven approach to the provision of

comprehensive transfer agency services. Founded in 1971, AST has grown to

be the largest independent stock transfer agent in the United States.



    Stockholders seeking information regarding stock transfer, lost

certificates, and address changes may contact AST as follows:








     For General Information



     American Stock Transfer & Trust Company

     59 Maiden Lane

     New York, NY

     10038

     http://www.amstock.com

     Stockholder Toll-Free line: 1-800-937-5449

     World Wide:                 1-718-921-8200

     Fax:                        1-718-236-2641

    About China-Biotics, Inc.



    Headquartered in Shanghai, China-Biotics, Inc. ("China-Biotics", "the

Company") was founded in 1999 and is one of China's largest suppliers of

probiotics. Probiotics are beneficial live bacteria used as dietary

supplements and food additives to improve intestinal health and digestion.

The Company's product portfolio contains live microbials made with

proprietary technology. Currently, these products are sold over-the-counter

under the "Shining" brand through large distributors to more than 1,000

pharmacies and 100 supermarkets in Shanghai, Jiangsu and Zhejiang. Shining

is one of the most recognized brands in Shanghai. China-Biotics plans to

expand its retail sales to other major cities in China and is launching 300

Shining brand logistic centers in these cities. The Company's flagship

product, "Shining Essence", has been a profit driver since its launch in

April 2001. There is a significant demand for probiotics for use in the

bulk additive market, which is currently met by imports. China-Biotics is

building a new plant which will increase its production capacity manifolds

to capture this market. For more information, please visit

http://www.chn-biotics.com .



    Safe Harbor Statement Under the Private Securities Litigation Reform

Act of 1995: Any statements set forth above that are not historical facts

are forward-looking statements that involve risks and uncertainties that

could cause actual results to differ materially from those in the

forward-looking statements. Such factors include, but are not limited to,

the Company's ability to market existing and new products, ability to

access capital for expansion, changes from anticipated levels of sales,

future national or regional economic and competitive conditions, changes in

relationships with customers, dependence on its flagship product profits

and other factors detailed from time to time in the Company's filings with

the United States Securities and Exchange Commission and other regulatory

authorities. The Company undertakes no obligation to publicly update or

revise any forward-looking statements, whether as a result of new

information, future events or otherwise.






    For more information, please contact:



    CCG Investor Relations

     Crocker Coulson, President

     Tel:   +1-646-213-1915 (New York)

     Email: [email protected]

     Web:   http://www.ccgir.com